ArticleInfection and drug resistance2026
The Red Cell Distribution Width to Albumin Ratio as a Novel Prognostic Predictor in Patients with Severe Fever with Thrombocytopenia Syndrome: A Multicenter Study in China.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Severe Fever with Thrombocytopenia Syndrome (SFTS) is an emerging infectious disease characterized by high mortality rate. This study aimed to explore the predictive ability of the red blood cell distribution width to albumin ratio (RAR) for mortality risk in SFTS. Patients and Methods: A total of 650 hospitalized SFTS patients from two centers were randomly assigned to a training (N = 455) and validation (N = 195) cohort at a 7:3 ratio. Independent risk factors were identified by constructing the LASSO regression model and Cox regression model. The predictive power and clinical benefit of risk factors were assessed using receiver operating characteristic (ROC) and decision curve analysis (DCA), respectively, with the nomogram visualizing the model. Kaplan-Meier curve and the Log rank test were employed to compare survival probabilities. Results: The 650 patients had a median age of 66 years. Deceased exhibited a significantly higher RAR value than survivors (4.61 vs 3.77, Conclusion: Baseline higher RAR levels were associated with an increased risk of death in SFTS patients. RAR may serve as a valuable predictor of mortality in SFTS patients during the early stage of disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.